Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50558084 (CHEMBL4799933) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 740 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Uncompetitive inhibition of recombinant human full length Avi-tagged p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2(DE3) using 20 uM... | Citation and Details Article DOI: 10.1021/acsmedchemlett.5b00396 BindingDB Entry DOI: 10.7270/Q2930XVT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50558084 (CHEMBL4799933) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | 3.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Competitive inhibition of recombinant human full length Avi-tagged p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2(DE3) using 20 uM A... | Citation and Details Article DOI: 10.1021/acsmedchemlett.5b00396 BindingDB Entry DOI: 10.7270/Q2930XVT | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50424917 (CHEMBL2311578) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid PDB UniChem Similars | PDB Article PubMed | n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of recombinant human full length Avi-tagged p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2(DE3) using 100 uM ATP as subst... | Citation and Details Article DOI: 10.1021/acsmedchemlett.5b00396 BindingDB Entry DOI: 10.7270/Q2930XVT | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468106 (CHEMBL4280801 | US11247985, Table 3.49) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536747 (US11247985, Table 3.51) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468106 (CHEMBL4280801 | US11247985, Table 3.49) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536749 (US11247985, Table 3.53) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50514013 (CHEMBL4445673 | US11247985, Table 3.55) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536753 (US11247985, Table 3.57) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468108 (CHEMBL4280125 | US11247985, Table 3.59) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PDB US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50158905 (CHEMBL3787674 | US11247985, Table 3.61) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468112 (CHEMBL4277404 | US11247985, Table 3.63) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 41 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536761 (US11247985, Table 3.65 | US11247985, Table 3.78) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468110 (CHEMBL4288865 | US11247985, Table 3.67) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50158905 (CHEMBL3787674 | US11247985, Table 3.61) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Curated by ChEMBL | Assay Description Inhibition of wild type human AAA ATPase p97 expressed in Escherichia coli measured by ADPGlo assay in presence of 100 uM ATP | ACS Med Chem Lett 6: 1225-30 (2015) Article DOI: 10.1021/acsmedchemlett.5b00364 BindingDB Entry DOI: 10.7270/Q2C82C6S | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468110 (CHEMBL4288865 | US11247985, Table 3.67) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468108 (CHEMBL4280125 | US11247985, Table 3.59) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem | PDB Article PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536765 (US11247985, Table 3.69) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 82 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536767 (US11247985, Table 3.71) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536769 (US11247985, Table 3.73) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 87 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468112 (CHEMBL4277404 | US11247985, Table 3.63) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536771 (US11247985, Table 3.75) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 92 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536773 (US11247985, Table 3.77) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468118 (CHEMBL4280546 | US11247985, Table 3.1) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536775 (US11247985, Table 3.79) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468123 (CHEMBL4291440 | US11247985, Table 3.97) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536781 (US11247985, Table 3.85) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536779 (US11247985, Table 3.83) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536777 (US11247985, Table 3.81) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536783 (US11247985, Table 3.87) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536785 (US11247985, Table 3.89) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468116 (CHEMBL4276697 | US11247985, Table 3.91) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536791 (US11247985, Table 3.95) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468123 (CHEMBL4291440 | US11247985, Table 3.97) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468105 (CHEMBL4288427 | US11247985, Table 3.99) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536789 (US11247985, Table 3.93) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536705 (US11247985, Table 3.9) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536801 (US11247985, Table 3.105) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536799 (US11247985, Table 3.103) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536797 (US11247985, Table 3.101) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536809 (US11247985, Table 3.113) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536803 (US11247985, Table 3.107) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536807 (US11247985, Table 3.111) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536805 (US11247985, Table 3.109) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536811 (US11247985, Table 3.115) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468118 (CHEMBL4280546 | US11247985, Table 3.1) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536703 (US11247985, Table 3.7) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468115 (CHEMBL4278176 | US11247985, Table 3.117) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 175 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM50468115 (CHEMBL4278176 | US11247985, Table 3.117) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Pittsburgh Chemical Diversity Center Curated by ChEMBL | Assay Description Inhibition of recombinant full length human p97 (1 to 806 residues) expressed in Escherichia coli Rosetta 2 (DE3) using 100 uM ATP as substrate after... | ACS Med Chem Lett 9: 1075-1081 (2018) Article DOI: 10.1021/acsmedchemlett.8b00372 BindingDB Entry DOI: 10.7270/Q23F4SBJ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Transitional endoplasmic reticulum ATPase (Homo sapiens (Human)) | BDBM536815 (US11247985, Table 3.119) | PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 180 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description To optimize p97 inhibitors, the C-5 trifluoromethylated trifluoromethylated indole 12 was generated as a promising lead structure. In the ADP-Glo ass... | Citation and Details BindingDB Entry DOI: 10.7270/Q25Q509B | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 497 total ) | Next | Last >> |